Aclaris Therapeutics (ACRS) Operating Margin (2017 - 2026)
Aclaris Therapeutics (ACRS) posted Operating Margin of -1487.91% for Q2 2026, down 452.00 percentage points from -1035.90% a year earlier and down 376.08 percentage points from the prior quarter.
Aclaris Therapeutics (ACRS) Operating Margin (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Operating Margin at Aclaris Therapeutics was -1050.16%, down 176.75 percentage points year-over-year; for FY2025, it came in at -975.91%, down 217.73 percentage points from FY2024.
- Annual Operating Margin has declined for three consecutive years, with a five-year change of -190.48 percentage points (FY2020 to FY2025).
- In prior years, Aclaris Therapeutics' Operating Margin was -758.18% in FY2024 (-446.63 pp), -311.55% in FY2023 (-9.54 pp), -302.01% in FY2022 (+1025.06 pp) and -1327.07% in FY2021 (-541.63 pp).
- Quarterly Operating Margin has run from a low of -1755.52% in Q4 2025 to a high of -23.03% in Q4 2023 over five years.
- On a year-over-year basis, Operating Margin increased in two of the last eight quarters, with an average year-over-year change of -407.21 percentage points.
- The strongest year-over-year quarter for Operating Margin in the past five years was Q2 2024, with a gain of 1237.53 percentage points; the weakest was Q4 2024, with a drop of 1059.10 percentage points.
- According to Business Quant data, Operating Margin for the three prior quarters was -1111.82% (Q1 2026), -1755.52% (Q4 2025) and -519.82% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Aclaris Therapeutics | 759.25 Mn | 759.25 Mn | 1.41 Mn | -1,487.91% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,487.91% |
| Mar 31, 2026 | -1,111.82% |
| Dec 31, 2025 | -1,755.52% |
| Sep 30, 2025 | -519.82% |
| Jun 30, 2025 | -1,035.90% |
| Mar 31, 2025 | -1,242.89% |
| Dec 31, 2024 | -1,082.13% |
| Sep 30, 2024 | -240.93% |
| Jun 30, 2024 | -464.71% |
| Mar 31, 2024 | -789.45% |
| Dec 31, 2023 | -23.03% |
| Sep 30, 2023 | -340.20% |
| Jun 30, 2023 | -1,702.25% |
| Mar 31, 2023 | -1,183.47% |
| Dec 31, 2022 | -375.07% |
| Sep 30, 2022 | -109.76% |
| Jun 30, 2022 | -1,373.95% |
| Mar 31, 2022 | -1,301.24% |
| Dec 31, 2021 | -1,525.18% |
| Sep 30, 2021 | -1,223.33% |
Aclaris Therapeutics Operating Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-margin&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-margin", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-margin&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();